The p38-MAPK inhibitor and garcinol synergistically increase the expression of cyclin E, p21Waf1/Cip1, and p27Kip1 and induce G1 cell cycle arrest and apoptosis in lung cancer cells. Here, CDKN1B is linked to lung carcinoma.